Annual CFO:
$572.84M+$413.58M(+259.69%)Summary
- As of today, BMRN annual cash from operations is $572.84 million, with the most recent change of +$413.58 million (+259.69%) on December 31, 2024.
- During the last 3 years, BMRN annual cash from operations has risen by +$268.31 million (+88.10%).
- BMRN annual cash from operations is now at all-time high.
Performance
BMRN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$185.27M+$10.88M(+6.24%)Summary
- As of today, BMRN quarterly cash from operations is $185.27 million, with the most recent change of +$10.88 million (+6.24%) on June 30, 2025.
- Over the past year, BMRN quarterly cash from operations has increased by +$66.51 million (+56.00%).
- BMRN quarterly cash from operations is now -16.35% below its all-time high of $221.48 million, reached on September 30, 2024.
Performance
BMRN Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$766.77M+$66.51M(+9.50%)Summary
- As of today, BMRN TTM cash from operations is $766.77 million, with the most recent change of +$66.51 million (+9.50%) on June 30, 2025.
- Over the past year, BMRN TTM cash from operations has increased by +$437.91 million (+133.16%).
- BMRN TTM cash from operations is now at all-time high.
Performance
BMRN TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BMRN Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +259.7% | +56.0% | +133.2% |
3Y3 Years | +88.1% | +229.5% | +544.2% |
5Y5 Years | +1086.9% | +568.0% | +391.2% |
BMRN Cash From Operations Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +259.7% | -16.4% | +350.6% | at high | +453.4% |
5Y | 5-Year | at high | +1086.9% | -16.4% | +350.6% | at high | +798.2% |
All-Time | All-Time | at high | +351.4% | -16.4% | +208.1% | at high | +359.2% |
BMRN Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $185.27M(+6.2%) | $766.77M(+9.5%) |
Mar 2025 | - | $174.39M(-6.1%) | $700.26M(+22.2%) |
Dec 2024 | $572.84M(+259.7%) | $185.63M(-16.2%) | $572.84M(+38.1%) |
Sep 2024 | - | $221.48M(+86.5%) | $414.70M(+26.1%) |
Jun 2024 | - | $118.76M(+152.8%) | $328.86M(+17.4%) |
Mar 2024 | - | $46.97M(+70.9%) | $280.16M(+75.9%) |
Dec 2023 | $159.26M(-9.5%) | $27.48M(-79.7%) | $159.26M(+14.9%) |
Sep 2023 | - | $135.65M(+93.6%) | $138.56M(-14.1%) |
Jun 2023 | - | $70.06M(+194.8%) | $161.24M(+9.4%) |
Mar 2023 | - | -$73.93M(-1189.5%) | $147.40M(-16.2%) |
Dec 2022 | $175.90M(-42.2%) | $6.79M(-95.7%) | $175.90M(-2.4%) |
Sep 2022 | - | $158.32M(+181.6%) | $180.30M(+51.5%) |
Jun 2022 | - | $56.23M(+223.8%) | $119.03M(-18.2%) |
Mar 2022 | - | -$45.43M(-506.4%) | $145.59M(-52.2%) |
Dec 2021 | $304.54M(+256.7%) | $11.18M(-88.5%) | $304.54M(+8.8%) |
Sep 2021 | - | $97.06M(+17.2%) | $279.97M(+4.0%) |
Jun 2021 | - | $82.78M(-27.1%) | $269.12M(+25.7%) |
Mar 2021 | - | $113.51M(+948.1%) | $214.07M(+150.8%) |
Dec 2020 | $85.36M(+76.9%) | -$13.38M(-115.5%) | $85.36M(-45.3%) |
Sep 2020 | - | $86.21M(+210.8%) | $156.09M(+11.5%) |
Jun 2020 | - | $27.74M(+282.6%) | $140.01M(+59.2%) |
Mar 2020 | - | -$15.19M(-126.5%) | $87.94M(+82.2%) |
Dec 2019 | $48.26M(+138.8%) | $57.34M(-18.2%) | $48.26M(+19.8%) |
Sep 2019 | - | $70.13M(+388.1%) | $40.29M(+132.0%) |
Jun 2019 | - | -$24.34M(+55.6%) | $17.37M(+121.3%) |
Mar 2019 | - | -$54.87M(-211.1%) | $7.85M(-61.2%) |
Dec 2018 | $20.21M(+330.8%) | $49.37M(+4.6%) | $20.21M(+238.9%) |
Sep 2018 | - | $47.20M(+239.4%) | -$14.55M(+38.0%) |
Jun 2018 | - | -$33.86M(+20.4%) | -$23.46M(-180.4%) |
Mar 2018 | - | -$42.51M(-390.9%) | $29.18M(+433.2%) |
Dec 2017 | -$8.76M(+96.2%) | $14.61M(-61.8%) | -$8.76M(+62.9%) |
Sep 2017 | - | $38.29M(+103.9%) | -$23.58M(+67.4%) |
Jun 2017 | - | $18.78M(+123.3%) | -$72.24M(+47.2%) |
Mar 2017 | - | -$80.44M(>-9900.0%) | -$136.83M(+39.9%) |
Dec 2016 | -$227.84M(-2.7%) | -$210.00K(+98.0%) | -$227.84M(+23.0%) |
Sep 2016 | - | -$10.37M(+77.4%) | -$295.83M(-2.6%) |
Jun 2016 | - | -$45.80M(+73.3%) | -$288.31M(-12.9%) |
Mar 2016 | - | -$171.45M(-151.4%) | -$255.33M(-15.1%) |
Dec 2015 | -$221.85M(-198.9%) | -$68.20M(-2293.0%) | -$221.85M(-23.0%) |
Sep 2015 | - | -$2.85M(+77.8%) | -$180.43M(+3.3%) |
Jun 2015 | - | -$12.83M(+90.7%) | -$186.61M(-0.7%) |
Mar 2015 | - | -$137.97M(-415.3%) | -$185.31M(-149.7%) |
Dec 2014 | -$74.21M(-24.4%) | -$26.78M(-196.5%) | -$74.21M(-26.4%) |
Sep 2014 | - | -$9.03M(+21.7%) | -$58.73M(+0.8%) |
Jun 2014 | - | -$11.53M(+57.1%) | -$59.19M(-8.7%) |
Mar 2014 | - | -$26.87M(-137.9%) | -$54.48M(+8.6%) |
Dec 2013 | -$59.63M(-438.7%) | -$11.30M(-19.0%) | -$59.63M(-64.0%) |
Sep 2013 | - | -$9.49M(-39.2%) | -$36.35M(-187.5%) |
Jun 2013 | - | -$6.82M(+78.7%) | -$12.65M(-74.5%) |
Mar 2013 | - | -$32.03M(-367.2%) | -$7.25M(-141.2%) |
Dec 2012 | $17.61M(-6.1%) | $11.99M(-15.7%) | $17.61M(+223.2%) |
Sep 2012 | - | $14.21M(+1101.0%) | $5.45M(+5634.7%) |
Jun 2012 | - | -$1.42M(+80.2%) | $95.00K(-99.4%) |
Mar 2012 | - | -$7.17M(-3997.7%) | $15.08M(-19.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $18.75M(+0.0%) | -$175.00K(-102.0%) | $18.75M(+496.1%) |
Sep 2011 | - | $8.86M(-34.7%) | $3.15M(-5.9%) |
Jun 2011 | - | $13.57M(+487.7%) | $3.34M(-72.1%) |
Mar 2011 | - | -$3.50M(+77.8%) | $12.00M(-36.0%) |
Dec 2010 | $18.75M(-78.6%) | -$15.78M(-274.3%) | $18.75M(-65.3%) |
Sep 2010 | - | $9.06M(-59.2%) | $53.99M(-27.0%) |
Jun 2010 | - | $22.22M(+583.7%) | $74.01M(+4.3%) |
Mar 2010 | - | $3.25M(-83.3%) | $70.96M(-19.1%) |
Dec 2009 | $87.73M(+1056.2%) | $19.47M(-33.0%) | $87.73M(+21.5%) |
Sep 2009 | - | $29.07M(+51.6%) | $72.23M(+60.4%) |
Jun 2009 | - | $19.17M(-4.2%) | $45.04M(+36.2%) |
Mar 2009 | - | $20.02M(+404.7%) | $33.06M(+460.4%) |
Dec 2008 | -$9.18M(+73.4%) | $3.97M(+110.5%) | -$9.18M(+17.2%) |
Sep 2008 | - | $1.89M(-73.8%) | -$11.08M(+51.2%) |
Jun 2008 | - | $7.19M(+132.4%) | -$22.70M(+38.0%) |
Mar 2008 | - | -$22.22M(-1176.6%) | -$36.59M(-6.1%) |
Dec 2007 | -$34.49M(+31.1%) | $2.06M(+121.2%) | -$34.49M(+27.1%) |
Sep 2007 | - | -$9.73M(-45.3%) | -$47.29M(+5.6%) |
Jun 2007 | - | -$6.70M(+66.7%) | -$50.10M(+1.4%) |
Mar 2007 | - | -$20.13M(-87.5%) | -$50.84M(-1.5%) |
Dec 2006 | -$50.09M(+20.1%) | -$10.73M(+14.5%) | -$50.09M(+13.7%) |
Sep 2006 | - | -$12.55M(-68.7%) | -$58.03M(+14.1%) |
Jun 2006 | - | -$7.44M(+61.6%) | -$67.57M(-6.1%) |
Mar 2006 | - | -$19.38M(-3.8%) | -$63.65M(-1.6%) |
Dec 2005 | -$62.68M(+3.8%) | -$18.67M(+15.4%) | -$62.68M(-17.2%) |
Sep 2005 | - | -$22.08M(-526.6%) | -$53.48M(-3.9%) |
Jun 2005 | - | -$3.52M(+80.9%) | -$51.47M(+25.9%) |
Mar 2005 | - | -$18.40M(-94.4%) | -$69.51M(-6.7%) |
Dec 2004 | -$65.14M(+12.9%) | -$9.46M(+52.9%) | -$65.14M(+26.5%) |
Sep 2004 | - | -$20.08M(+6.9%) | -$88.66M(+2.8%) |
Jun 2004 | - | -$21.56M(-53.7%) | -$91.22M(-18.4%) |
Mar 2004 | - | -$14.03M(+57.5%) | -$77.03M(-3.0%) |
Dec 2003 | -$74.80M(-39.6%) | -$32.99M(-45.7%) | -$74.80M(+1.6%) |
Sep 2003 | - | -$22.64M(-206.9%) | -$76.01M(-27.7%) |
Jun 2003 | - | -$7.38M(+37.5%) | -$59.52M(-4.3%) |
Mar 2003 | - | -$11.80M(+65.5%) | -$57.06M(-6.5%) |
Dec 2002 | -$53.59M(-132.4%) | -$34.20M(-456.0%) | -$53.59M(-113.9%) |
Sep 2002 | - | -$6.15M(-25.2%) | -$25.06M(-0.3%) |
Jun 2002 | - | -$4.91M(+41.1%) | -$24.99M(-12.4%) |
Mar 2002 | - | -$8.33M(-47.1%) | -$22.24M(+3.6%) |
Dec 2001 | -$23.07M(-78.9%) | -$5.66M(+7.0%) | -$23.07M(-13.8%) |
Sep 2001 | - | -$6.09M(-181.5%) | -$20.27M(-27.9%) |
Jun 2001 | - | -$2.16M(+76.4%) | -$15.85M(+2.2%) |
Mar 2001 | - | -$9.15M(-219.1%) | -$16.21M(-25.7%) |
Dec 2000 | -$12.90M(+0.3%) | -$2.87M(-72.4%) | -$12.90M(+2.3%) |
Sep 2000 | - | -$1.66M(+34.0%) | -$13.21M(+27.3%) |
Jun 2000 | - | -$2.52M(+56.9%) | -$18.17M(-23.7%) |
Mar 2000 | - | -$5.84M(-83.8%) | -$14.69M(-13.5%) |
Dec 1999 | -$12.94M(-60.6%) | -$3.18M(+52.0%) | -$12.94M(-32.6%) |
Sep 1999 | - | -$6.63M(-790.8%) | -$9.76M(-211.3%) |
Jun 1999 | - | $959.10K(+123.4%) | -$3.14M(+23.4%) |
Mar 1999 | - | -$4.09M | -$4.09M |
Dec 1998 | -$8.06M(-161.1%) | - | - |
Dec 1997 | -$3.09M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual cash from operations?
- What is the all-time high annual cash from operations for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual cash from operations year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly cash from operations year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM cash from operations year-on-year change?
What is BioMarin Pharmaceutical Inc. annual cash from operations?
The current annual cash from operations of BMRN is $572.84M
What is the all-time high annual cash from operations for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual cash from operations is $572.84M
What is BioMarin Pharmaceutical Inc. annual cash from operations year-on-year change?
Over the past year, BMRN annual cash from operations has changed by +$413.58M (+259.69%)
What is BioMarin Pharmaceutical Inc. quarterly cash from operations?
The current quarterly cash from operations of BMRN is $185.27M
What is the all-time high quarterly cash from operations for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly cash from operations is $221.48M
What is BioMarin Pharmaceutical Inc. quarterly cash from operations year-on-year change?
Over the past year, BMRN quarterly cash from operations has changed by +$66.51M (+56.00%)
What is BioMarin Pharmaceutical Inc. TTM cash from operations?
The current TTM cash from operations of BMRN is $766.77M
What is the all-time high TTM cash from operations for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM cash from operations is $766.77M
What is BioMarin Pharmaceutical Inc. TTM cash from operations year-on-year change?
Over the past year, BMRN TTM cash from operations has changed by +$437.91M (+133.16%)